Published Mar 10, 2025

Improve Focus with Behavioral Tools & Medication for ADHD | Dr. John Kruse

Andrew Huberman and Dr. John Kruse dive into ADHD, debunking misconceptions and exploring comprehensive strategies for management, from cognitive-behavioral therapy and lifestyle tweaks to the nuanced world of medications, shedding light on their benefits, risks, and how they shape attention and life expectancy.
Episode Highlights
Huberman Lab logo

Popular Clips

Episode Highlights

  • Stimulant Risks

    Stimulant medications like Adderall and Vyvanse are commonly used to treat ADHD, but they come with potential risks. highlights the importance of a thorough medical history and monitoring for cardiovascular issues, as long-term use can increase risks of heart problems, although these remain low for most people 1. He also discusses amphetamine-induced psychosis, a rare but severe side effect that can persist long after stopping the medication 2. Kruse notes that while amphetamines are effective, their potential for severe side effects necessitates careful consideration 3.

       

    Non-Stimulants

    Non-stimulant medications like guanfacine offer an alternative for ADHD treatment, working differently than traditional stimulants. explains that guanfacine strengthens synaptic connections in the prefrontal cortex, which may take weeks to manifest effects 4. Unlike stimulants, guanfacine is often sedating, making it suitable for nighttime use, and is sometimes used in combination with other medications 5. adds that guanfacine's slower action is due to its modulation of neural pathways, contrasting with the immediate effects of stimulants 5.

       

    Medication Effects

    Comparing ADHD medications reveals distinct differences in their mechanisms and effects. notes that stimulants like Ritalin and amphetamines are highly effective but can suppress growth in children 6. Modafinil, often used for cognitive enhancement, acts on the orexin system rather than norepinephrine, offering a non-stimulant approach 7. suggests that ADHD medications aim to make neuromodulators like dopamine more accessible, enhancing focus and attention 8.

Related Episodes